Search Count: 17
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 3
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: DMS, RY5 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: DMS, RY5
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: SQ2, PEG, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: SQ2, PEG, DMS
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 1
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: SQ5, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: SQ5, DMS
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 6
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: DMS, SYH |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: DMS, SYH
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 8
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: DMS, T0W |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: DMS, T0W
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 13
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: DMS, TU8 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: DMS, TU8
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 21
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: DMS, U7W |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: DMS, U7W
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 15
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: U9H, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: U9H, DMS
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 17
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: V18 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: V18
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Nsp5) In Complex With Compound 18
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2022-02-23 Classification: VIRAL PROTEIN Ligands: DMS, V1B |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-02-23
Ligands: DMS, V1B
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: WM9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-06-26
Ligands: WM9
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: 2FB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-06-26
Ligands: 2FB
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: DMS, 54M |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-06-26
Ligands: DMS, 54M
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: KGG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-06-26
Ligands: KGG
 |
New Aminoimidazoles As Bace-1 Inhibitors: From Rational Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-10-10 Classification: HYDROLASE Ligands: DMS, 1B1 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-10-10
Ligands: DMS, 1B1
 |
New Aminoimidazoles As Bace-1 Inhibitors: From Rational Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-10-10 Classification: HYDROLASE Ligands: ACT, 6TG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-10-10
Ligands: ACT, 6TG
 |
New Aminoimidazoles As Bace-1 Inhibitors: From Rational Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-10-10 Classification: HYDROLASE Ligands: 6T6 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-10-10
Ligands: 6T6